METRO confirms it has signed the Canadian Grocery Industry Code of Conduct. "Since 2021, we have actively contributed with the Retail Council of Canada and industry stakeholders to the development of ...

A 2025 NJBIZ In the Lead Family-Owned Businesses honoree, the chain now has 14 other locations across three states. Tommy’s ...

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC ...

PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider ...

Based on the Results of a Planned Interim Futility Analysis the Inhaled AAT Trial is Unlikely to Demonstrate a Statistically ...

Newron announces US initiation of its ENIGMA-TRS 2 Phase III global study of evenamide for patients with treatment-resistant ...

ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no ...

T'puram: Opposition leader V D Satheesan said Kerala is facing a crisis of governance, and the state has witnessed an ...

Thanks to the research of two professors at UW-Platteville, there may truly be no reason to ever cry over spilled milk.

Data featured in an ASH oral presentation; LINKER-MM4 is the first clinical trial to evaluate a BCMAxCD3 bispecific monotherapy in NDMM and is part of a broad clinical development program evaluating ...

MIT researchers developed a compact band-pass Raman spectroscopy device that noninvasively tracks glucose through the skin in ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced updated data from its ongoing Phase 1b study evaluating R2891, an ...